Why METH users are at high risk of fatality due to COVID-19 infection?
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2020 |
|---|---|
| Erschienen: |
2020 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:19 |
|---|---|
| Enthalten in: |
Expert review of vaccines - 19(2020), 12 vom: 28. Dez., Seite 1101-1103 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Hossain, Md Kamal [VerfasserIn] |
|---|
| Links: |
|---|
| Anmerkungen: |
Date Completed 25.02.2021 Date Revised 25.02.2021 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1080/14760584.2020.1858059 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM318163462 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM318163462 | ||
| 003 | DE-627 | ||
| 005 | 20231225164800.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2020 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1080/14760584.2020.1858059 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1060.xml |
| 035 | |a (DE-627)NLM318163462 | ||
| 035 | |a (NLM)33249941 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Hossain, Md Kamal |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Why METH users are at high risk of fatality due to COVID-19 infection? |
| 264 | 1 | |c 2020 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 25.02.2021 | ||
| 500 | |a Date Revised 25.02.2021 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Editorial | |
| 650 | 4 | |a Research Support, Non-U.S. Gov't | |
| 650 | 4 | |a COVID-19 | |
| 650 | 4 | |a METH addiction | |
| 650 | 4 | |a SARS-CoV-2 | |
| 650 | 4 | |a coronavirus | |
| 650 | 4 | |a drug addiction | |
| 650 | 4 | |a lung infection | |
| 650 | 4 | |a methamphetamine | |
| 650 | 4 | |a substance abuse | |
| 650 | 4 | |a vaccine | |
| 650 | 7 | |a Antibodies, Neutralizing |2 NLM | |
| 650 | 7 | |a COVID-19 Vaccines |2 NLM | |
| 650 | 7 | |a Central Nervous System Stimulants |2 NLM | |
| 650 | 7 | |a Methamphetamine |2 NLM | |
| 650 | 7 | |a 44RAL3456C |2 NLM | |
| 700 | 1 | |a Hassanzadeganroudsari, Majid |e verfasserin |4 aut | |
| 700 | 1 | |a Apostolopoulos, Vasso |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Expert review of vaccines |d 2002 |g 19(2020), 12 vom: 28. Dez., Seite 1101-1103 |w (DE-627)NLM126545200 |x 1744-8395 |7 nnns |
| 773 | 1 | 8 | |g volume:19 |g year:2020 |g number:12 |g day:28 |g month:12 |g pages:1101-1103 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1080/14760584.2020.1858059 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 19 |j 2020 |e 12 |b 28 |c 12 |h 1101-1103 | ||